Pascal M. Jabbour, MD
Angela & Richard T. Clark Distinguished Professor; and Division Chief for Neurovascular Surgery & Endovascular Surgery
Contact
909 Walnut Street
2nd Floor
Philadelphia, Pennsylvania 19107
215-955-7000
215-503-7038 fax
Pascal M. Jabbour, MD
Angela & Richard T. Clark Distinguished Professor; and Division Chief for Neurovascular Surgery & Endovascular Surgery
Education
Medical School
St. Joseph's University, Beirut, Lebanon
Residency
Hotel Dieu de France Hospital (Beirut)
University of Colorado
Thomas Jefferson University
Fellowship
Vascular Neurosurgery ,Thomas Jefferson University Hospital
Publications
- The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis
- Treatment of large intracranial aneurysms using the Woven EndoBridge (WEB): a propensity score-matched analysis
- Complex intracranial aneurysms: a DELPHI study to define associated characteristics
- Dual Layer vs Single Layer Woven EndoBridge Device in the Treatment of Intracranial Aneurysms: A Propensity Score-Matched Analysis
- Endovascular intervention for carotid blowout syndrome and predictors of recurrence: A retrospective and multicenter cohort study
Board Certification
Neurological Surgery
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
Languages
English, French, Arabic
Expertise & Research Interests
Dr. Jabbour is a vascular neurosurgeon who is dually trained in open surgical techniques as well as minimally invasive endovascular surgical techniques. He treats patients with diseases in the blood vessels in their neck, brain, or spinal cord. He also treats pediatric patients with retinoblastoma with selective intra-arterial chemotherapy. Dr. Jabbour is a pioneer in the field of trans-radial access for neurointerventions and has begun to implement the use of robots in endovascular neurosurgery. Dr Jabbour has published more than 500 papers in peer reviewed journals that are based on his clinical research, which has given Jefferson patients access to novel clinical trials for aneurysms and other vascular issues.